Propanc Biopharma, Inc. (PPCB): Valuation
TTM figures as of March 31, 2026
Propanc Biopharma, Inc. trades at a -199.09% free-cash-flow yield. That FCF yield is higher than 79% of its own month-end history back to 2013.
Earnings yield -875.00%. ROIC -146.9%.
164 month-end valuation observations are on file, starting January 2013.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is PPCB cheap versus its own history?
Propanc Biopharma, Inc. trades at a -199.09% free-cash-flow yield. That FCF yield is higher than 79% of its own month-end history back to 2013.
What is PPCB's free-cash-flow yield?
Propanc Biopharma, Inc. currently yields -199.09% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.